Beta
223165

Expression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study

Article

Last updated: 03 Jan 2025

Subjects

-

Tags

-

Abstract

Background: Breast cancer (BC) is the most common cancer worldwide and is the main cause of cancer related death in women. Forkhead boxp3(FOXP3) is a transcription factor that plays an important role in the development and function of immune regulatory T cells (Tregs). A strong relation between the COX-2/PGE2 pathway and FOXP3-positive Tregs has been proposed.
Objective: We implemented this study to evaluate the prognostic significance of FOXP3 and COX-2 expression and relation with overall survival in BC patients.
Patients and Methods: This study was conducted on archival cases of 66 BC patients. Tumor infiltrating lymphocytes was evaluated in H&E slides whether peri-tumoral or intra-tumoral and were classified as absent, low, moderate, and high infiltration. Sections from each case were stained for FOXP3 and Cyclo-oxygenase 2(COX2). Expression of FOXP3 was assessed in malignant epithelial tissues and in tumor infiltrating lymphocytes (intra-tumoral and peri-tumoral). Expression of COX-2 was assigned in tumor epithelial cells and correlated with overall survival.
Results: Higher FOXP3 H. scores in epithelial cells were associated with younger age, low grade tumors, non-triple negative group. Higher FOXP3 H. scores in peri-tumoral lymphocytes were significantly associated with young age. Higher H. scores of COX2 expression was associated with PR negative cases. OS was improved in patients with high infiltration by peri-tumoral infiltrating lymphocytes and high FOXP3 positive intra-tumoral lymphocytes scores.
Conclusions: Dense TILs as well as high FOXP3 expression are considered as good prognostic factors. On the other hand, COX2 might be considered to have poor prognostic role.
 

 
 
 

DOI

10.21608/ejhm.2022.223165

Keywords

Tumor infiltrating lymphocytes, foxp3, Cox2, Immunohistochemical expression, breast cancer

Authors

First Name

Hagar A.

Last Name

Alagizy

MiddleName

-

Affiliation

-

Email

hagar76@hotmail.com

City

-

Orcid

-

First Name

Hayam Abdel-Samie

Last Name

Aiad

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Moshira Mohamed

Last Name

Abdel-Wahed

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Mahmoud Abdelsattar

Last Name

Elshenawy

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Heba Gaber

Last Name

Abou-Sheishai

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Hala Said

Last Name

El-Rebey

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

87

Article Issue

1

Related Issue

31467

Issue Date

2022-04-01

Receive Date

2022-03-06

Publish Date

2022-04-01

Page Start

1,216

Page End

1,225

Print ISSN

1687-2002

Online ISSN

2090-7125

Link

https://ejhm.journals.ekb.eg/article_223165.html

Detail API

https://ejhm.journals.ekb.eg/service?article_code=223165

Order

39

Type

Original Article

Type Code

606

Publication Type

Journal

Publication Title

The Egyptian Journal of Hospital Medicine

Publication Link

https://ejhm.journals.ekb.eg/

MainTitle

Expression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study

Details

Type

Article

Created At

22 Jan 2023